1The Institute of Public Health, University of Southern Denmark, Odense, Denmark.
Clin Rehabil. 2014 Mar;28(3):243-53. doi: 10.1177/0269215513500057. Epub 2013 Sep 10.
To examine whether patients assessed for initiation of oral intake only by Facial-Oral Tract Therapy had a greater risk of developing aspiration pneumonia during neurorehabilitation than patients assessed by Fibreoptic Endoscopic Evaluation of Swallowing.
Randomized controlled trial.
Specialized, national neurorehabilitation centre.
Adult patients with acquired brain injury. Six hundred and seventy-nine patients were assessed for eligibility and 138 were randomly allocated between June 2009 and April 2011.
Assessment by Facial-Oral Tract Therapy (control group) or Fibreoptic Endoscopic Evaluation of Swallowing (intervention group).
Primary outcome was the number of aspiration pneumonias that developed after initiation of oral intake.
One hundred and nineteen patients were included in the analysis of the primary outcome (62 controls/57 interventions). Sixteen patients were clinically diagnosed with pneumonia (4 controls/12 interventions). Nine patients had to be excluded: 6 patients got pneumonia before initiating oral intake; 3 patients with the clinical diagnosis of pneumonia did not show radiological signs. Seven patients were left for analysis, 4 of whom developed aspiration pneumonia within 10 days after initiating oral intake (1 control/3 interventions).
In the presence of a structured clinical assessment with the Facial-Oral Tract Therapy approach, it is unnecessary to undertake an instrumental investigation of swallowing before initiation of oral intake.
研究仅通过口腔面部治疗评估开始口服摄入的患者与通过纤维内镜吞咽评估进行评估的患者相比,在神经康复期间发生吸入性肺炎的风险是否更高。
随机对照试验。
专门的国家神经康复中心。
患有后天性脑损伤的成年患者。对 679 名患者进行了资格评估,2009 年 6 月至 2011 年 4 月期间随机分配了 138 名患者。
口腔面部治疗评估(对照组)或纤维内镜吞咽评估(干预组)。
主要结局是开始口服摄入后发生的吸入性肺炎的数量。
119 名患者被纳入主要结局(62 名对照组/57 名干预组)的分析。16 名患者被临床诊断为肺炎(4 名对照组/12 名干预组)。有 9 名患者必须被排除:6 名患者在开始口服摄入前就患有肺炎;3 名具有肺炎临床诊断的患者没有显示出放射学迹象。7 名患者被留下进行分析,其中 4 名在开始口服摄入后 10 天内发生了吸入性肺炎(1 名对照组/3 名干预组)。
在使用口腔面部治疗方法进行结构化临床评估的情况下,在开始口服摄入之前没有必要进行吞咽的仪器检查。